drugset / Trial / NCT02293460
Efficacy and Safety Study of I10E in Treatment of Patients With CIDP
NaSingle-groupOpen-labelTreatment
Summary
Primary objective: To assess the efficacy of I10E in improving the disability of patients with CIDP. Secondary objective: To assess the safety of I10E in patients with CIDP.
Timeline
- Start
- 2015-05
- Primary completion
- 2017-09-29
- Completion
- 2017-09-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | I10E | Protein / enzyme biologic | 1 g/kg | — |